Cepacidine A is a potent antifungal antibiotic produced by Pseudomonas cepacia AF 2001. The compound was isolated from the fermentation broth with 1 vol isopropyl alcohol, followed by the collection of the precipitation formed upon concentration of the extract. Purification was effected by chromatography on Diaion HP-20, alumina and reversed phase C18 followed by TLC on silica gel. These techniques afforded the two closely related compounds, cepacidine A1 and cepacidine A2. A mixture of these two compoundscalled cepacidine A, showed high in vitro antifungal activity against the various animal and plant pathogenic fungi. The activity was diminished by the presence of serum. No antibacterial activity was demonstrable.
In the course of our screening for newantifungal substances from the various microorganisms, a novel antifungal antibiotic, named cepacidine A, was found in the fermentation broth of a strain of Pseudomonas cepacia AF 2001, deposited in the Korean Federation of Culture Collections, Seoul, Korea, with the registration number KFCC10773. Cepacidine A is a mixture of two closely related compounds, cepacidine At and cepacidine A2. The primary structures of these two compoundsare shown in Fig. 1 . The producing organism, Pseudomonas cepacia AF2001, was isolated from the soil samples collected in Munchon, Kyunggi-Do, Korea.
In this paper we describe the taxonomy of the producing microorganism, the producing and isolation procedures of cepacidine A, and their biological activity. The results of physico-chemical properties and structural elucidation are presented in the accompanying report. 1}
Taxonomy
The strain AF 2001, producing cepacidine A, is a Gram-negative rod sized 0.4~0.6 x 1.0~1.3 /xm and motile by means of polar flagella. It is oxidative and cytochrome positive. These characteristics serve to identify the strain as a Pseudomonas. A summaryof the key characteristics and the carbon utilization pattern for the growths is shown in Table 1 . These characteristics are very similar to the description for Pseudomonas cepacia given by Ballard et al.2) However, strain AF 2001 is different from Pseudomonas cepacia as mentioned above in reference to maltose, sucrose and adonitol utilization. It can grow on maltose and sucrose as a sole carbon source but it cannot grow on adonitol. In these points, strain AF 2001 is thought to be new Pseudomonascepacia. Therefore, we designated the strain Pseudomonascepacia cultures we're prepared on agar slants composed of glucose 3%, peptone 1.5% and agar 2%. The slants were incubated at 28°C for 24 hours and used to inoculate germinator flasks containing 100 ml of medium in 500-ml Erlenmeyer flasks. This medium consisted of bactopeptone 1%, yeast extract 1%and glucose 3%. The germinator was incubated for 24hours at 28°C on a rotary shaker at 300rpm, and then used to inoculate (1 %) the same medium (10 liters). The fermentation was run for 72 hours at 28°C with an agitation rate of 300rpm.Progress of the fermentation and the subsequent isolation steps were monitored by Cepacidine A1 R=OH Cepacidine A2 R=H paper-disc-agar diffusion assay, with Candida albicans ATCC38245 as the assay microorganism.
Isolation Procedure Cepacidine A was isolated and purified by the procedure outlined in Fig. 2 . The fermentation broth, 10liters, was mixed with equal volumes of isopropanol (10 liters), and the mixture was adjusted to pH 4.0 with cone HC1. The mixture was centrifuged and the cell mass was discarded. The supernatant was concentrated then under reduced pressure to remove isopropanol. The precipitate that formed during the concentration process contained the bioactivity as shown by conventional agar diffusion assay. The concentrate and the accompanying precipitate were stored at 4°C for 6hours to allow the precipitation to proceed to completion. The precipitate was collected by filtration with diatomaceous earth, washed with water and then eluted with 50% isopropanol in water. This solution was concentrated in vacuo to removeisopropanol. After extraction of this concentrate with iso-butanol -methanol (8 : 2), the solvent extract was then concentrated under reduced pressure. The precipitate that formed during the concentration was collected by centrifugation and dissolved in 50% isopropanol adjusted to pH 10.0 with NaOH.This solution was diluted with lOvol distilled water and applied to Diaion HP-20resin column chromatography. After elution with 50% isopropanol, the eluent was concentrated in vacuo into a small volume. The precipitate formed during the concentration was dissolved in 50%isopropanol and applied to alumina column chromatography. The pass through that contained the bioactivity was concentrated into a small volume and stored at 4°C for 24 hours to allow precipitation. After washing with water, the precipitate was dissolved in 50%isopropanol and applied on a preparative ODS-silica gel column of Waters /x-Bondapak C18 (3 x 30cm, 10fim) and developed with acetonitrile -water (6 : 4, pH 3.5). The fraction containing anti-candidal activity was collected and concentrated in vacuo in order to give residues of pure cepacidine A (100mg). Cepacidine A was further resolved into two closely related components, i.e., Ax and A2, by TLCon silica gel (Merck Silica gel 60 F254), eluting with isopropanol-cone ammonia-water (4 : 2 : 1). Visualization of the components was accomplished either by charring, after spraying with a solution containing 5% ammoniummolibdate and 0.1 %eerie ammoniumsulfate in 10%sulfuric acid, or by spraying conventional ninhydrin reagent. The Rfvalue of Ax and A2 is 0.53 and 0.58, respectively. The producing ratio ofA1 and A2 was determined to 9 : 1 according to the quantitative analysis of the amounts of purified A^^and A2. Unfortunately, it was very difficult to isolate large amount of pure A± and A2, because cepacidine A was not separated into At and A2 using the HPLCsystem described above. Therefore, the mixture of Ax and A2was used for the following studies, i.e., biological activity, physicochemical properties and structural elucidation.
Biological
Activity The in vitro antifungal activity of cepacidine A and amphotericin B against a wide range of medically important fungi are shown in Table 2 . The activity was determined by the two fold agar dilution methodon potato dextrose agar medium. Cepacidine Aexhibited a broad antifungal spectrum against all strains tested. In particular, cepacidine A was highly active against dermatophytes, namely Microsporum canis, Trichophyton spp., and Epidermophyton spp., and true yeast at concentrations lower than 0.049^g/ml. The activities of cepacidine Awere greater than those of amphotericin B in almost all strains. However, no antibacterial activity was detected (MIC> 100^g/ml) when cepacidine A was assayed against the bacteria i.e.: Bacillus subtilis, Escherichia coli, Staphylococcusaureus and Pseudomonas aeruguinosa. The effects of humanserum upon the antifungal activity of cepacidine A was determined by a standard microtiter dilution assay prepared in the presence of 50% humanserum. Controls consisted of wells without serum. The results are shown in Table 3 . It is evident that the activity is diminished about eight fold in the case of Cryptococcus neoformans and sixteen fold in Candida albicans by the presence of serum. Until now, it has not been determined if the loss of activity is due to serum binding or degradation ofcepacidine A.
